About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 3

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

A Multicenter, Open-label Extension Trial to Assess the Long-term Safety and Tolerability of Lacosamide as Adjunctive Therapy in Subjects With Partial-onset Seizures

NCT00655486•UCB BIOSCIENCES, Inc.

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Partial EpilepsiesPartial Onset Seizures

Interventions

lacosamide

Locations

7

United States

Locations (7)

Phoenix, Arizona, United States

Baltimore, Maryland, United States

Chesterfield, Missouri, United States

Columbus, Ohio, United States

Philadelphia, Pennsylvania, United States

Dallas, Texas, United States

Key Dates

Start Date

April 1, 2008

Primary Completion Date

June 1, 2010

Completion Date

June 1, 2010

Last Updated

July 17, 2018

Related Studies

Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness

NCT06960811

Epilepsy With Partial Onset Seizures With or Without Secondary GeneralizationPsychoses+1 more

A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)

NCT01830868

Partial Onset Seizures

COMPLETEDPhase 4

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

NCT03288129

Partial Onset SeizuresSecondarily Generalized Seizures+1 more

COMPLETEDPhase 3

A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.

NCT02072824

Partial Onset Seizures

COMPLETEDPhase 2

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

NCT00552305

Partial Epilepsies

COMPLETEDPhase 3

A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures

NCT01710657

EpilepsyPartial Onset Seizures

View all related studies

Sponsors

Lead Sponsor

UCB BIOSCIENCES, Inc.

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 17, 2018Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions